Paris - Delayed Quote EUR

Acticor Biotech SAS (ALACT.PA)

0.3360 +0.0660 (+24.44%)
At close: April 26 at 5:35 PM GMT+2
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Expense
16,655.0000
15,102.0000
11,831.0000
7,562.0000
Operating Income
-16,655.0000
-15,102.0000
-11,831.0000
-7,562.0000
Net Non Operating Interest Income Expense
-1,997.0000
-778.0000
-777.0000
-94.0000
Pretax Income
-18,649.0000
-15,878.0000
-12,608.0000
-7,651.0000
Net Income Common Stockholders
-18,649.0000
-15,878.0000
-12,608.0000
-7,651.0000
Diluted NI Available to Com Stockholders
-18,649.0000
-15,878.0000
-12,608.0000
-7,651.0000
Basic EPS
-1.67
-1.49
-1.62
-0.73
Diluted EPS
-1.67
-1.49
-1.62
-0.73
Basic Average Shares
11,088.6580
10,545.7760
7,780.2920
10,545.7760
Diluted Average Shares
11,088.6580
10,545.7760
7,780.2920
10,545.7760
Total Operating Income as Reported
-16,672.0000
-15,121.0000
-11,889.0000
-7,576.0000
Rent Expense Supplemental
362.0000
108.0000
64.0000
121.0000
Total Expenses
16,655.0000
15,102.0000
11,831.0000
7,562.0000
Net Income from Continuing & Discontinued Operation
-18,649.0000
-15,878.0000
-12,608.0000
-7,651.0000
Normalized Income
-18,649.0000
-15,878.0000
-12,608.0000
-7,651.0000
Interest Income
481.0000
8.0000
2.0000
--
Interest Expense
2,460.0000
766.0000
721.0000
--
Net Interest Income
-1,997.0000
-778.0000
-777.0000
-94.0000
EBIT
-16,189.0000
-15,112.0000
-11,887.0000
-7,651.0000
EBITDA
-16,056.0000
-15,026.0000
-11,787.0000
-7,542.0000
Reconciled Depreciation
133.0000
86.0000
96.0000
99.0000
Net Income from Continuing Operation Net Minority Interest
-18,649.0000
-15,878.0000
-12,608.0000
-7,651.0000
Normalized EBITDA
-16,056.0000
-15,026.0000
-11,787.0000
-7,542.0000
12/31/2020 - 11/1/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers